Form 0920-25-0177 Study Visit Survey

[NCHHSTP] The GAIN (Greater Access and Impact with NAT) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)

Att 4c Study Visit Survey

Study Visit Survey

OMB: 0920-1357

Document [docx]
Download: docx | pdf


Form Approved

OMB No. 0920-1357

Expiration Date: XX\XX\XXXX








The Greater Access and Impact with NAT (GAIN) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs)



Attachment 4c

Study Visit Survey




















Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-1357)

Shape3 Study Visit Survey





Shape4

Study ID

Shape5


Study ID does not match. Please double-check and re-enter.


Visit Type HIV testing

Shape8 PEP

PrEP start

PrEP persistence HIV-positive (RCT)

Shape9 HIV-positive (Gay City)


Which study group was this person randomized to? Standard of Care POC NAT


HIV status at start of visit negative/unknown positive


Please confirm visit type and/or HIV status. The two fields currently do not match.


Do you want to participate in an additional survey, Yes

Shape14 which will be sent to you via email? (This survey will No only be sent if you have negative point-of-care HIV

test results.)

Shape15



Form Approved

OMB No. 0920-1357

Expiration Date: XX\XX\XXXX

Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-1357)





Shape20



Shape21 American Indian or Alaska Native


Enter, for example, Navajo Nation, Blackfeet Tribe of

the Blackfeet Indian Reservation of Montana, Native Village of Barrow Inupiat Traditional Government, Nome

Eskimo Community, Aztec, Maya, etc.





Shape24

Asian - provide details below.



Shape25

Chinese Filipino Korean

Shape26

Asian Indian Vietnamese Japanese

Enter, for example, Pakistani, Hmong, Afghan, etc.



Shape27




Shape29 Black or African American - provide details below.


African American Jamaican Haitian Nigerian

Shape31 Shape32 Shape33 Ethiopian Somali


Enter, for example, Trinidadian and Tobagonian, Ghanaian, Congolese, etc.

Shape35




Shape37

Hispanic or Latino - provide details below.



Shape40 Shape38 Shape39

Mexican Salvadoran Dominican

Shape41

Puerto Rican Cuban Guatemalan

Enter, for example, Columbian, Honduran, Spaniard, etc.






Shape43 Middle Eastern or North African - provide details below.


Lebanese Iranian

Shape45 Shape46 Shape47 Egyptian Syrian Iraqi Israeli


Enter, for example, Moroccan, Yemeni, Kurdish, etc.

Shape49




Shape51 Native Hawaiian or Pacific Islander - provide details below.


Native Hawaiian Samoan Chamorro Tongan

Shape53 Shape54 Shape55 Fijian Marshallese


Enter, for example, Chuukese, Palauan, Tahitian, etc.

Shape57




Shape59 White - provide details below.


English German

Shape61 Shape62 Shape63 Irish Italian Polish Scottish


Enter, for example, French, Swedish, Norwegian, etc.

Shape65


What is your sex? Male

Shape67 Female



Do you have health insurance? Yes, I have public insurance (i.e. Apple health, Medicaid, Medicare)

Shape69 Yes, I have private insurance

Yes, I have something different (i.e. VA, DoD, other)

Shape70 No, I do not have any health insurance Not sure


What is your health insurance type?

Shape72


What is the highest grade in school you completed? Less than high school

Shape74 Some high school

High school diploma or GED

Some college, Associate's degree, or Technical degree

Shape75 College graduate

Post graduate or professional school I prefer not to answer


Shape77 Where have you been living most of the time during the In my own home or apartment

past 30 days? In the home/apartment of friends/family (couch surfing, I am not on the lease)

Supportive housing (housing with additional services onsite, like a case manager)

Shape78 Single room occupancy hotel (SRO) Transitional housing

Overnight shelter

In a tent or encampment, on the street or in a car Other


Where have you been living most of the time during the past 30 days?

Shape80

Shape81

Never Yes

Cannabis (marijuana, pot, grass, hash, etc.)

Cocaine (coke, crack, etc.)

Methamphetamine (speed, crystal meth, ice, etc.)

Hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)


Opioids (heroin, opium, fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin])

Methadone or buprenorphine Other substances

Shape82

Injected Smoked Ingested Other

Shape83 Shape84 Shape85 Shape86 Cannabis (marijuana, pot, grass, hash, etc.)

Shape87 Shape88 Shape89 Shape90 Cocaine (coke, crack, etc.)

Shape91 Shape92 Shape93 Shape94 Methamphetamine (speed, crystal meth, ice, etc.)

Shape95 Shape96 Shape97 Shape98 Hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)


Shape99 Shape100 Shape101 Shape102 Opioids (heroin, opium, fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin])

Shape103 Shape104 Shape105 Shape106 Shape107 Shape108 Shape109 Shape110 Methadone or buprenorphine Other substances


Please specify the other substances you have used in the previous three months:

Shape112


Shape114 Have you ever used HIV pre-exposure prophylaxis, or No, I have never taken PrEP

PrEP? PrEP is a pill to prevent getting HIV. Yes, I have previously taken PrEP but do not use it now

Yes, I am currently using PrEP


When did you last stop taking PrEP? Please enter a

month and year in MM/YYYY format. If you cannot remember the month, please just enter the year. (MM/YYYY)


Have you ever taken HIV antiretroviral therapy, or No, I have never taken ART

Shape117 ART? ART is a medication to treat HIV. Yes, I have previously taken ART but am not currently taking it

Yes, I am currently on ART


Thank you for your responses! Please return the laptop to study staff.

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Modified0000-00-00
File Created2026-01-14

© 2026 OMB.report | Privacy Policy